Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 48, 2018 - Issue 7
121
Views
1
CrossRef citations to date
0
Altmetric
Xenobiotic Transporters

Effect of inhalation exposure to toluene on the activity of organic anion transporting polypeptide (Oatp) using pravastatin as a probe drug in rats

, , , &
Pages 734-738 | Received 06 Jun 2017, Accepted 06 Jul 2017, Published online: 25 Jul 2017

References

  • Agency for Toxic Substances and Disease Registry – ATSDR (2000). Toxicological profile for toluene. Atlanta: U.S. Department of Health and Human Services, Public Health Service p. 357. Available at: www.atsdr.cdc.gov/February 2016.
  • American Conference of Governmental Industrial Hygienists - ACGIH (2011). Documentation of the threshold limit values for chemical substances and physical agents and biological exposure indices. Cincinnati, OH, CD-ROM.
  • Amisaki T. (2001). Gaussian quadrature as a numerical integration method for estimating area under the curve. Biol Pharm Bull 24:70–7.
  • Badolo L, Bundgaard C, Garmer M, et al. (2013). The role of hepatic transport and metabolism in the interactions between pravastatin or repaglinide and two rOatp inhibitors in rats. Eur J Pharm Sci 49:767–72.
  • Capela JMV, Capela MV, Lepera JS. (2012). Estimação da área sob a curva para dados farmacocinéticos obtidos por amostragem esparsa. In: 34° CongressoNacional de matemática aplicada e computacional. Águas de Lindóia, Brazil: UNESP.
  • Cardoso JL, Lanchote VL, Pereira MP, et al. (2013). Influence of gasoline inhalation on the enantioselective pharmacokinetics of fluoxetine in rats. Chirality 25:206–10.
  • Cardoso JL, Lanchote VL, Pereira MP, et al. (2015). Impact of inhalational exposure to ethanol fuel on the pharmacokinetics of verapamil, ibuprofen and fluoxetine as in vivo probe drugs for CYP3A, CYP2C and CYP2D in rats. Food Chem Toxicol 84:99–105.
  • Chen LC, Lippmann M. (2016). Inhalation toxicology methods: the generation and characterization of exposure atmospheres and inhalation exposures. Curr Protoc Toxicol 63:24.4.1–23.
  • Chia SE, Tan KT, Kwok SK. (1987). A study on the health hazard of toluene in the polythene printing industry in Singapore. Ann Acad Med Singapore 16:294–9.
  • Dorato MA, Wolff RK. (1991). Inhalation exposure technology, dosimetry, and regulatory issues. Toxicol Pathol 19:373–83.
  • Everett DW, Chando TJ, Didonato GC, et al. (1991). Biotransformation of pravastatin sodium in humans. Drug Metab Dispos 19:740–8.
  • Furman GM, Silverman DM, Schatz RA. (1998). Inhibition of rat lung mixed function oxidase acitivity following repeated low-level toluene inhalation: possible role of toluene metabolites. J Toxicol Environ Health 54:633–45.
  • Hatanaka T. (2000). Clinical pharmacokinetics of pravastatin: mechanisms of pharmacokinetic events. Clin Pharmacokinet 39:397–412.
  • Hsiang B, Zhu Y, Wang Z, et al. (1999). A novel human hepatic organic anion transporting polypeptide (OATP2). Identification of a liver-specific human organic anion transporting polypeptide and identification of rat and human hydroxymethylglutaryl-CoA reductase inhibitor transporters . J Biol Chem 274:37161–8.
  • Jacobsen W, Kirchner G, Hallensleben K, et al. (1999). Comparison of cytochrome P-450-dependent metabolism and drug interactions of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors lovastatin and pravastatin in the liver. Drug Metab Dispos 27:173–9.
  • Kotsampasakou E, Brenner S, Jager W, Ecker GF. (2015). Identification of novel inhibitors of organic anion transporting polypeptides 1B1 and 1B3 (OATP1B1 and OATP1B3) using a consensus vote of six classification models. Mol Pharm 12:4395–404.
  • Lee HH, Leake BF, Teft W, et al. (2015). Contribution of hepatic organic anion-transporting polypeptides to docetaxel uptake and clearance. Mol Cancer Ther 14:994–1003.
  • Lepera JS, Colacioppo S. (2005). Occupational exposure to paint solvents and particulate material in car repair shops. Revista Brasileira de Toxicologia 18:49–55.
  • Mateus FH, Lepera JS, Marques MP, et al. (2008). Reduction of enantioselectivity in the kinetic disposition and metabolism of verapamil in rats exposed to toluene. Can J Physiol Pharmacol 86:232–9.
  • Mateus FH, Lepera JS, Marques MP, et al. (2010). Influence of N-hexane inhalation on the enantioselective pharmacokinetics and metabolism of verapamil in rats. Chirality 22:29–34.
  • Nakagomi-Hagihara R, Nakai D, Tokui T, et al. (2007). Gemfibrozil and its glucuronide inhibit the hepatic uptake of pravastatin mediated by OATP1B1. Xenobiotica 37:474–86.
  • Naritomi Y, Terashita S, Kimura S, et al. (2001). Prediction of human hepatic clearance from in vivo animal experiments and in vitro metabolic studies with liver microsomes from animals and humans. Drug Metab Dispos 29:1316–24.
  • Tayel SA, Nabarawi MAE, Tadros MI, et al. (2015). Duodenum-triggered delivery of pravastatin sodium via enteric surface-coated nanovesicular spanlastic dispersions: development, characterization and pharmacokinetic assessments. Int J Pharm 483:77–88.
  • Wang RS, Nakajima T, Tsuruta H, et al. (1996). Effect of exposure to four organic solvents on hepatic cytochrome P450 isozymes in rat. Chem Biol Interact 99:239–52.
  • Watanabe T, Kusuhara H, Maeda K, et al. (2009). Physiologically based pharmacokinetic modelling to predict transporter-mediated clearance and distribution of pravastatin in humans. J Pharmacol Exp Ther 328:652–62.
  • Wong BA. (2007). Inhalation exposure systems: design, methods and operation. Toxicol Pathol 35:3–14.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.